Drupal.behaviors.print = function(context) {window.print();window.close();}>
Sequenom Launches MaterniT21 Down Syndrome Test as LDT, Publishes Clinical Validation Study
October 19, 2011
Sequenom Launches MaterniT21 Down Syndrome Test as LDT, Publishes Clinical Validation Study
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Sequenom Runs More Than 13K T21 Tests in Q2; Plans to Expand Capacity in US and Overseas
August 1, 2012 / Clinical Sequencing News
As MaterniT21 Drives Spike in Diagnostic Revenue, Sequenom Predicts 25K Tests Sold in 2012
March 14, 2012 / Clinical Sequencing News
Sequenom Sees Steady Growth of MaterniT21 Test Despite Competition
June 6, 2012 / Clinical Sequencing News
Sequenom Plans Sample-Prep Automation, Increased Multiplexing to Double MaterniT21 Capacity
May 9, 2012 / Clinical Sequencing News
Verinata Licenses Quake Patent, Setting Stage for IP Tussle with Sequenom
September 7, 2011 / Clinical Sequencing News